Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/1/2025

Mechanism of Action of Megestrol Acetate in Endometriosis

Molecular Mechanisms

  • The American College of Obstetricians and Gynecologists notes that megestrol acetate modifies progesterone receptor expression (PR-A and PR-B ratio), maintaining tissue quiescence 1
  • The drug can work through both genomic and non-genomic pathways, providing multiple points of therapeutic intervention 1

Anti-Inflammatory Effects

  • The American College of Obstetricians and Gynecologists reports that progestins like megestrol acetate decrease prostaglandin synthesis and infection-mediated cytokine production in endometrial tissues 1, 2
  • This anti-inflammatory action counteracts the inflammatory cascade that contributes to endometriosis-related pain 2

Clinical Implications for Reproductive-Age Women

  • The American Society for Reproductive Medicine states that megestrol acetate does NOT improve future fertility outcomes and should not be used in women actively seeking pregnancy, with a strength of evidence level of limited or low quality 3

REFERENCES

3

Management of Endometriosis-Related Pelvic Pain [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025